BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8077344)

  • 1. Leukemia after a small dose of radioiodine for metastatic thyroid cancer.
    Bitton R; Sachmechi I; Benegalrao Y; Schneider BS
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1423-6. PubMed ID: 8077344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute leukemias after treatment with radioiodine for thyroid cancer.
    Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
    Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
    Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
    J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
    Shimon I; Kneller A; Olchovsky D
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases.
    Focosi D; Galimberti S; Petrini M
    Haematologica; 2007 Sep; 92(9):e96-7. PubMed ID: 17768141
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.
    Laurenti L; Salutari P; Sica S; Piccirillo N; Zini G; Zollino M; Leone G
    Ann Hematol; 1998 Jun; 76(6):271-2. PubMed ID: 9692815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
    Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
    J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma.
    Van Nostrand D; Atkins F; Yeganeh F; Acio E; Bursaw R; Wartofsky L
    Thyroid; 2002 Feb; 12(2):121-34. PubMed ID: 11916281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients.
    Schlumberger M; De Vathaire F; Ceccarelli C; Delisle MJ; Francese C; Couette JE; Pinchera A; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):606-12. PubMed ID: 8691249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.
    Oluwasanjo A; Pathak R; Ukaigwe A; Alese O
    Cancer Causes Control; 2016 Jan; 27(1):143-6. PubMed ID: 26453198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Seo GH; Cho YY; Chung JH; Kim SW
    Thyroid; 2015 Aug; 25(8):927-34. PubMed ID: 26133388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer.
    Kulkarni K; Van Nostrand D; Atkins F; Aiken M; Burman K; Wartofsky L
    Thyroid; 2006 Oct; 16(10):1019-23. PubMed ID: 17042688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of bone marrow toxicity in elderly patients treated with recombinant human thyroid-stimulating hormone and empirically dosed radioiodine for thyroid cancer.
    Amdur RJ; Dan T; Mazzaferri E
    Am J Clin Oncol; 2013 Aug; 36(4):348-53. PubMed ID: 22547013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
    Wang KL; Lin LY; Chen PM; Lin HD
    J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
    Pavithran K; Doval DC
    Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
    de Vathaire F
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
    Bal CS; Kumar A; Pant GS
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131I therapy of thyroid cancer patients.
    Reiners C; Farahati J
    Q J Nucl Med; 1999 Dec; 43(4):324-35. PubMed ID: 10731783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.